Vaccine Results Positive in First Human Trial
The first COVID-19 vaccine to reach clinical trials in humans was determined to be both safe and generate an immune response against the virus — a “milestone” in the battle to defeat the deadly bug, a new study found • Full Story
Matzav
The first COVID-19 vaccine to reach clinical trials in humans was determined to be both safe and generate an immune response against the virus — a “milestone” in the battle to defeat the deadly bug, a new study found.
A single dose of the vaccine was found to produce virus-fighting antibodies and T cells, a type of immune cell, two weeks after it’s administered, according to the peer-reviewed study, published Friday in the journal The Lancet.
“These results represent an important milestone,” said the lead researcher on the study, Professor Wei Chen.
239
Join ChabadInfo's News Roundup and alerts for the HOTTEST Chabad news and updates!
Related Posts:
Most Popular
New Videos
Editor's Picks
